HomeVNDA • NASDAQ
add
Vanda Pharmaceuticals Inc.
Previous close
$4.63
Day range
$4.50 - $4.63
Year range
$3.30 - $6.75
Market cap
262.60M USD
Avg Volume
535.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 50.47M | 9.59% |
Operating expense | 57.89M | 27.44% |
Net income | -4.52M | -397.24% |
Net profit margin | -8.95 | -371.21% |
Earnings per share | — | — |
EBITDA | -8.18M | -261.06% |
Effective tax rate | 18.09% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 387.68M | -20.78% |
Total assets | 651.37M | 1.51% |
Total liabilities | 108.86M | 6.95% |
Total equity | 542.52M | — |
Shares outstanding | 58.29M | — |
Price to book | 0.50 | — |
Return on assets | -3.89% | — |
Return on capital | -4.60% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -4.52M | -397.24% |
Cash from operations | -6.93M | 47.59% |
Cash from investing | -15.26M | 92.00% |
Cash from financing | — | — |
Net change in cash | -22.20M | 89.12% |
Free cash flow | -8.81M | 46.15% |
About
Founded
2002
Headquarters
Website
Employees
203